Contact
Please use this form to send email to PR contact of this press release:
Biogenum Announces Favorable Safety Profile for Tau NonTangles™ in a Phase 1/2 Clinical Trial in Patients with Alzheimer
TO:
Alice Lum
Biogenum
+82 1855552863